Macular Degeneration

Clinical Trials

Below is a list of Macular Degeneration clinical trials from the clinical trials database at Mayo Clinic.

This list includes only trials about which Mayo researchers choose to publish information. Mayo Clinic may be conducting other trials which are not in this database. Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.

A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
The purpose of this research study is to determine if ranibizumab is safe and is well tolerated when given in multiple doses for the treatment of neovascular (wet) age-related macular degeneration (AMD).
Read more

The Age-Related Eye Disease Study 2 (AREDS2)
This study is being done to learn what role nutritional pills with lutein and zeaxanthin and/or omega-3 long-chain polyunsaturated fatty acids, specifically docosahexaenoic acid (DHA) and icosapentaenoic acid (EPA), play in preventing or slowing the development of age-related macular degeneration (AMD) and cataract.

This study is supported by the National Eye Institute, part of the federal government's National Institutes of Health.
Read more